These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Receptor Tyrosine Kinase-Targeted Cancer Therapy. Yamaoka T; Kusumoto S; Ando K; Ohba M; Ohmori T Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30404198 [TBL] [Abstract][Full Text] [Related]
4. [Radiotherapy and inhibitors of epidermal growth factor receptor: preclinical findings and preliminary clinical trials]. Azria D; Larbouret C; Robert B; Culine S; Ychou M; Verrelle P; Dubois JB; Pèlegrin A Bull Cancer; 2003 Nov; 90 Spec No():S202-12. PubMed ID: 14763141 [TBL] [Abstract][Full Text] [Related]
5. Dasatinib, a multi-kinase inhibitor increased radiation sensitivity by interfering with nuclear localization of epidermal growth factor receptor and by blocking DNA repair pathways. Raju U; Riesterer O; Wang ZQ; Molkentine DP; Molkentine JM; Johnson FM; Glisson B; Milas L; Ang KK Radiother Oncol; 2012 Nov; 105(2):241-9. PubMed ID: 23010482 [TBL] [Abstract][Full Text] [Related]
6. Phosphatidylinositol 3-kinase/Akt signaling as a key mediator of tumor cell responsiveness to radiation. Toulany M; Rodemann HP Semin Cancer Biol; 2015 Dec; 35():180-90. PubMed ID: 26192967 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous β1 integrin-EGFR targeting and radiosensitization of human head and neck cancer. Eke I; Zscheppang K; Dickreuter E; Hickmann L; Mazzeo E; Unger K; Krause M; Cordes N J Natl Cancer Inst; 2015 Feb; 107(2):. PubMed ID: 25663685 [TBL] [Abstract][Full Text] [Related]
8. Integrative meta-modeling identifies endocytic vesicles, late endosome and the nucleus as the cellular compartments primarily directing RTK signaling. Weddell JC; Imoukhuede PI Integr Biol (Camb); 2017 May; 9(5):464-484. PubMed ID: 28436498 [TBL] [Abstract][Full Text] [Related]
9. Nuclear receptor tyrosine kinase transport and functions in cancer. Chen MK; Hsu JL; Hung MC Adv Cancer Res; 2020; 147():59-107. PubMed ID: 32593407 [TBL] [Abstract][Full Text] [Related]
10. Personalized Radiation Oncology: Epidermal Growth Factor Receptor and Other Receptor Tyrosine Kinase Inhibitors. Higgins GS; Krause M; McKenna WG; Baumann M Recent Results Cancer Res; 2016; 198():107-22. PubMed ID: 27318683 [TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-type 1 receptor inhibitor NVP-AEW541 enhances radiosensitivity of PTEN wild-type but not PTEN-deficient human prostate cancer cells. Isebaert SF; Swinnen JV; McBride WH; Haustermans KM Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):239-47. PubMed ID: 21816290 [TBL] [Abstract][Full Text] [Related]
12. Novel targeted radiosensitisers in cancer treatment. Zaidi SH; Huddart RA; Harrington KJ Curr Drug Discov Technol; 2009 Jun; 6(2):103-34. PubMed ID: 19519337 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit. Raju U; Molkentine DP; Valdecanas DR; Deorukhkar A; Mason KA; Buchholz TA; Meyn RE; Ang KK; Skinner H Cancer Med; 2015 Jan; 4(1):65-74. PubMed ID: 25355701 [TBL] [Abstract][Full Text] [Related]
14. Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapies. Hojjat-Farsangi M Int J Mol Sci; 2014 Aug; 15(8):13768-801. PubMed ID: 25110867 [TBL] [Abstract][Full Text] [Related]
15. Relationships between DNA repair and RTK-mediated signaling pathways. Chabot T; Cheraud Y; Fleury F Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188495. PubMed ID: 33346130 [TBL] [Abstract][Full Text] [Related]
16. The use of tyrosine kinase inhibitors in modifying the response of tumor microvasculature to radiotherapy. Lu B; Shinohara ET; Edwards E; Geng L; Tan J; Hallahan DE Technol Cancer Res Treat; 2005 Dec; 4(6):691-8. PubMed ID: 16292890 [TBL] [Abstract][Full Text] [Related]
17. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer. De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397 [TBL] [Abstract][Full Text] [Related]
18. Molecular Targeting of Growth Factor Receptor Signaling in Radiation Oncology. Huang S; Peter Rodemann H; Harari PM Recent Results Cancer Res; 2016; 198():45-87. PubMed ID: 27318681 [TBL] [Abstract][Full Text] [Related]
19. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer. Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749 [TBL] [Abstract][Full Text] [Related]
20. Roles for receptor tyrosine kinases in tumor progression and implications for cancer treatment. Ghosh S; Marrocco I; Yarden Y Adv Cancer Res; 2020; 147():1-57. PubMed ID: 32593398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]